Atomwise

About:

Atomwise develops artificial intelligence systems using powerful deep learning algorithms and supercomputers for drug discovery.

Website: http://www.atomwise.com

Twitter/X: atomwiseinc

Top Investors: Khosla Ventures, Tencent, Creative Destruction Lab (CDL), Y Combinator, Bill & Melinda Gates Foundation

Description:

Atomwise is a preclinical pharma company revolutionizing how drugs are discovered with AI. We invented the use of deep learning for structure-based drug discovery, today developing a pipeline of small-molecule drug candidates advancing into preclinical studies. Our AtomNet® technology has been used to unlock more undruggable targets than any other AI drug discovery platform. We are tackling over 600 unique disease targets with more than 250 partners around the world, including leading pharmaceutical, agrochemical, and emerging biotechnology companies. Atomwise has raised over $174 million from leading venture capital firms to advance our mission to make better medicines, faster. Learn more at atomwise.com, or connect on Twitter and LinkedIn.

Total Funding Amount:

$177M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

San Francisco, California, United States

Founded Date:

2012-01-01

Contact Email:

hello(AT)atomwise.com

Founders:

Abraham Heifets, Alex Levy, Izhar Wallach

Number of Employees:

51-100

Last Funding Date:

2020-10-06

IPO Status:

Private

© 2024 MyAiNote.com